Literature DB >> 3372677

A novel type of pituitary adenoma: morphological features and clinical correlations.

E Horvath1, K Kovacs, H S Smyth, D W Killinger, B W Scheithauer, R Randall, E R Laws, W Singer.   

Abstract

Twenty patients with a novel, frequently aggressive type of pituitary adenoma, termed silent subtype 3 adenoma on the basis of fine structural criteria, are reported. The surgically removed tumors were studied by morphological techniques, and the findings were correlated with clinical and biochemical data. All tumors were macroadenomas, often with parasellar extension. The histologically diffuse tumors frequently exhibited focal immunopositivity for one or more adenohypophysial hormones, although the majority of adenoma cells were negative. The tumors had characteristic electron microscopic features, assuring specific diagnosis and delineating this tumor type as a distinct ultrastructural entity. The tumors were removed from 9 women and 11 men (median ages, 27 and 41 yr, respectively). In all women, mild to moderate hyperprolactinemia and its sequelae were present from the early phase of the disease, leading to the erroneous diagnosis of prolactinoma. Bromocriptine therapy (3 patients) reduced serum PRL levels to normal, but failed to halt tumor growth. In men, most adenomas were nonfunctioning; 4 men had mild to moderate hyperprolactinemia. Three men had elevated serum GH levels and acromegaly, suggestive of multidirectional differentiation. Although the putative cell type giving rise to silent subtype 3 adenomas is not known, the tumor should be recognized to avoid erroneous diagnosis and inappropriate treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372677     DOI: 10.1210/jcem-66-6-1111

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  The silent corticotropinoma: is clinical diagnosis possible?

Authors:  B Ambrosi; P Colombo; D Bochicchio; M Bassetti; B Masini; G Faglia
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

2.  Subclinical Addison's disease mimicking a silent corticotroph adenoma.

Authors:  P Iglesias; J J Díez
Journal:  J Endocrinol Invest       Date:  2011-10       Impact factor: 4.256

Review 3.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

Review 4.  [New aspects of tumor pathology of the pituitary].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 5.  Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

Authors:  Odelia Cooper; Shlomo Melmed
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

6.  MGMT immunoexpression in silent subtype 3 pituitary adenomas: possible therapeutic implications.

Authors:  Michael E Fealey; Bernd W Scheithauer; Eva Horvath; Dana Erickson; Kalman Kovacs; Roger McLendon; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

7.  Collision tumors of the sella: craniopharyngioma and silent pituitary adenoma subtype 3: case report.

Authors:  Olga Moshkin; Bernd W Scheithauer; Luis V Syro; Alejandro Velasquez; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

8.  Endocrine surgical pathology: lesson from pituitary cases that are discordant between clinical and pathologic diagnoses.

Authors:  Toshiaki Sano; Shozo Yamada; Yasunori Ozawa; Akira Shimatsu
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

9.  Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.

Authors:  Ozgur Mete; Karen Gomez-Hernandez; Walter Kucharczyk; Rowena Ridout; Gelareh Zadeh; Fred Gentili; Shereen Ezzat; Sylvia L Asa
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

10.  In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.

Authors:  L Stefaneanu; K Kovacs; E Horvath; R V Lloyd
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.